Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126694) titled 'Validation of the Diagnostic Methodology of BOKE EyeScan for the Quantitative Measurement of the Angle of Strabismus' on June 14.
Study Type: Diagnostic test
Study Design:
Factorial
Primary Sponsor: Eye Hospital, Wenzhou Medical University at Hangzhou
Condition:
Strabismus
Intervention:
Gold Standard:Prism and Alternate Cover Test
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-15
Target Sample Size: Target condition:210;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=320330
Published by HT Dig...